Australia markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
237.45+6.44 (+2.79%)
At close: 04:00PM EDT
237.69 +0.24 (+0.10%)
After hours: 05:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.19B
Enterprise value 6.76B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.14
Price/book (mrq)12.57
Enterprise value/revenue 10.82
Enterprise value/EBITDA -396.16

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-9.40%
S&P500 52-week change 322.36%
52-week high 3330.00
52-week low 3123.27
50-day moving average 3207.10
200-day moving average 3202.07

Share statistics

Avg vol (3-month) 3504.73k
Avg vol (10-day) 3598.21k
Shares outstanding 530.3M
Implied shares outstanding 630.3M
Float 829.06M
% held by insiders 11.91%
% held by institutions 1104.09%
Shares short (15 Apr 2024) 42.31M
Short ratio (15 Apr 2024) 44.93
Short % of float (15 Apr 2024) 48.75%
Short % of shares outstanding (15 Apr 2024) 47.63%
Shares short (prior month 15 Mar 2024) 41.87M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -3.39%
Operating margin (ttm)4.83%

Management effectiveness

Return on assets (ttm)-4.05%
Return on equity (ttm)-3.96%

Income statement

Revenue (ttm)624.8M
Revenue per share (ttm)21.32
Quarterly revenue growth (yoy)39.60%
Gross profit (ttm)N/A
EBITDA -37.42M
Net income avi to common (ttm)-21.15M
Diluted EPS (ttm)-0.71
Quarterly earnings growth (yoy)368.70%

Balance sheet

Total cash (mrq)460.38M
Total cash per share (mrq)15.56
Total debt (mrq)24.85M
Total debt/equity (mrq)4.34%
Current ratio (mrq)7.60
Book value per share (mrq)19.37

Cash flow statement

Operating cash flow (ttm)24.65M
Levered free cash flow (ttm)380.62k